Bank Of New York Mellon Corp 9 Meters Biopharma, Inc. Transaction History

Bank Of New York Mellon Corp

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.26 - $0.64 $128,464 - $316,220	-494,095 Reduced 78.78%	133,105 $35,000
Q4 2021 Feb 11, 2022	BUY	$0.85 - $1.33 $13,288 - $20,793	15,634 Added 2.56%	627,200 $613,000
Q3 2021 Nov 12, 2021	BUY	$1.03 - $1.41 $133,919 - $183,326	130,019 Added 27.0%	611,566 $796,000
Q2 2021 Aug 11, 2021	BUY	$1.04 - $1.5 $440,305 - $635,056	423,371 Added 727.74%	481,547 $529,000
Q1 2021 May 13, 2021	BUY	$0.84 - $2.16 $48,867 - $125,660	58,176 New	58,176 $68,000

67.9K

Ticker NMTR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 12,955,400
Market Cap $259K
Description
9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.